-- 据《日经新闻》周四报道,随着日本自2011年福岛核事故以来首次考虑建造新的反应堆,日本核设备制造商正利用虚拟现实和数字工具加快员工培训。 IHI(东京证券交易所代码:7013)于今年1月推出了一项新的焊接培训项目,该项目结合了课堂教学、实践操作和通过配备摄像头的焊接面罩拍摄的视频资料。报道称,该公司表示,该系统可以将部分技术人员的培训时间缩短至之前的五分之一左右。 报道称,三菱重工(东京证券交易所代码:7011)已开发了约50门基于虚拟现实技术的课程,涵盖核电站的设计、建造和维护;而日立公司正在将其技术专长数字化,以改善其核电业务的知识转移。 报道指出,尽管人工智能驱动的电力消费需求不断增长,且政府对核电的支持力度加大,但日本核电行业仍面临着熟练劳动力短缺的问题。近期日本股市交易中,IHI股价上涨近6%,而三菱重工股价下跌近2%。 (市场动态消息来源于与全球市场专业人士的交流。我们认为这些信息来自可靠渠道,但可能包含传闻和推测。准确性无法保证。)
Related Articles
StarHub's Net Attributable Profit Falls 81% in Q1
StarHub's (SGX:CC3) net attributable profit to shareholders plunged 81% in the first quarter of the year to SG$5.9 million from SG$31.8 million a year earlier, according to a Thursday filing with the Singapore Exchange.Revenue declined 6.1% year over year to SG$507.3 million from SG$540.5 million, mainly due to an across-the-board decline in services revenue.
Meesho Narrows Consolidated Loss in Fiscal Q4
Meesho (NSE:MEESHO, BOM:544632) narrowed its consolidated attributable loss to 1.66 billion Indian rupees in the fiscal fourth quarter ended March 31, from a loss of 13.9 billion rupees a year ago.Loss per share contracted to 0.36 rupees from a loss per share of 3.39 rupees a year earlier, the online marketplace said in a filing to the Indian stock exchanges on Wednesday. The loss per share was lower than the 0.73 rupees estimated by the analysts polled by Visible Alpha.Revenue from operations in fiscal Q4 increased to 35.3 billion rupees from 24.0 billion rupees a year ago. This is a tad higher than Visible Alpha's estimate of 35.2 billion rupees a year ago.
Changchun High-Tech Gets Regulatory Nod for Gouty Arthritis Drug
Changchun High-Tech Industry (SHE:000661) subsidiary Changchun Genescience Pharmaceutical obtained China's regulatory approval to manufacture and market its fuxinqibai monoclonal antibody injection.The drug is indicated for acute gouty arthritis attacks in adults poorly responsive to standard therapies, according to a Thursday filing with the Shenzhen bourse.